This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Meroni, P L Articles by Caruso, A Search for Related Content PubMed PubMed Citation Articles by Meroni, P L Articles by Caruso, A Pubmed/NCBI databases Substance via MeSH Medline Plus Health Information High Risk Pregnancy Social Bookmarking                   What's this?

Antiphospholipid antibodies as cause of pregnancy loss

Allergy, Clinical Immunology and Rheumatology Unit, IRCCS Istituto Auxologico Italiano, Department of Internal Medicine, University of Milan, Milan, Italy, pierluigi.meroni{at}unimi.it

N di Simone

Department of Obstetrics and Gynecology, UniversitàCattolica del Sacro Cuore, Rome, Italy

C Testoni

Allergy, Clinical Immunology and Rheumatology Unit, IRCCS Istituto Auxologico Italiano, Department of Internal Medicine, University of Milan, Milan, Italy

M D’Asta

Department of Obstetrics and Gynecology, UniversitàCattolica del Sacro Cuore, Rome, Italy

B Acaia

Division of Obstetrics and Gynecology, ICP, Milan, Italy

A Caruso

Department of Obstetrics and Gynecology, UniversitàCattolica del Sacro Cuore, Rome, Italy

Antiphospholipid antibodies detected by lupus anticoagulant, anticardiolipin or anti-beta2 glycoprotein I assays were associated with fetal loss. Rather than being diagnostic tools only, antiphospholipid antibodies are thought to be pathogenic. The strongest demonstration of their pathogenic role lies in the ability to induce fetal resorptions - the experimental equivalents of the human fetal losses - when passively infused in pregnant naive animals. However, still debated is how the antibodies might induce the obstetrical manifestations. Thrombotic events at the placental levels might be related to endothelial cell activation, inhibition of protein C/S system and fibrinolysis as well as to Annexin V displacement. However, the thrombophilic state apparently cannot explain all the miscarriages and a direct antibody-mediated damage on the trophoblast has been suggested. During differentiation to syncytium, trophoblasts express cell membrane anionic phospholipids that can bind beta2 glycoprotein I, the main cationic phospholipid binding protein recognized by the antiphospholipid antibodies. Adhered b2-glycoprotein I might be recognized by the antibodies that, once bound, strongly interfere with in vitro trophoblast cell maturation so resulting in a defective placentation. These mechanisms have been suggested to play a role in early fetal loss, while thrombotic events would be responsible for miscarriages late in the pregnancy.

Key Words: antiphospholipid antibodies • fetal loss • trophoblast

Lupus, Vol. 13, No. 9, 649-652 (2004)
DOI: 10.1191/0961203304lu2001oa


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				Z Rotar, B Rozman, P. de Groot, M Sanmarco, Y Shoenfeld, P. Meroni, R Cervera, V Pengo, R Cimaz, T Avcin, et al. Sixth meeting of the European Forum on antiphospholipid antibodies. How to improve the understanding of the antiphospholipid syndrome? Lupus, January 1, 2009; 18(1): 53 - 60. [Abstract] [PDF]

				M. Motta, A. Tincani, P. L. Meroni, and R. Cimaz Follow-up of children exposed antenatally to immunosuppressive drugs Rheumatology, June 1, 2008; 47(suppl_3): iii32 - iii34. [Abstract] [Full Text] [PDF]

				Y. Martinez de la Torre, C. Buracchi, E. M. Borroni, J. Dupor, R. Bonecchi, M. Nebuloni, F. Pasqualini, A. Doni, E. Lauri, C. Agostinis, et al. Protection against inflammation- and autoantibody-caused fetal loss by the chemokine decoy receptor D6 PNAS, February 13, 2007; 104(7): 2319 - 2324. [Abstract] [Full Text] [PDF]

				F. A. Hills, V. M. Abrahams, B. Gonzalez-Timon, J. Francis, B. Cloke, L. Hinkson, R. Rai, G. Mor, L. Regan, M. Sullivan, et al. Heparin prevents programmed cell death in human trophoblast Mol. Hum. Reprod., April 1, 2006; 12(4): 237 - 243. [Abstract] [Full Text] [PDF]

				A Tincani, D Bompane, E Danieli, and A Doria Pregnancy, lupus and antiphospholipid syndrome (Hughes syndrome) Lupus, March 1, 2006; 15(3): 156 - 160. [Abstract] [PDF]